Sign In
Last checked at 
15 Apr 2013 07:00
15 April 2013
Iofina plc
("Iofina" or the "Company")
(LSE AIM: IOF)
Board Update
Iofina, a specialist in the exploration and production of iodine and specialty chemical iodine derivatives, is announcing that Mr. Lance Baller, the Company's Chief Executive Officer, Secretary and President, is taking a leave of absence for health reasons. Mr. Baller remains a member of the Board and will return to his role once his treatment is completed.
Accordingly, Non-Executive Chairman Dr. Chris Fay will assume the role of Executive Chairman. Non-executive Director Stuart Eaton will assume the role of Executive Operations Officer. Jeff Ploen will remain Non-Executive Deputy Chairman.
Commenting, Dr Chris Fay, stated: "We wish Lance and his family the very best at this difficult time and look forward to welcoming him back, fit and well in due course."
Trading continues in line with the board's expectations and the Company expects to be in a position to announce its final results in respect of the year ended 31 December 2012 in the near term.
For further information, please contact:
Stuart Eaton, Executive Operations Officer Iofina plc Tel: +44(0)7500 042 516 www.iofina.com | Dr Chris Fay, Executive Chairman Iofina plc Tel: +44(0)7747 693 486
|
Ben Colegrave/Chris Sim/Neil Elliot Investec Tel: +44(0)20 7597 5970
| Media Contact: Dominic Barretto/Anna Legge Yellow Jersey PR Limited Tel: +44(0) 7768 537 739 |
Follow the stocks
